Sargent Bickham Lagudis LLC Ark Genomic Revolution ETF (De Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
A detailed history of Sargent Bickham Lagudis LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 435 shares of ARKG stock, worth $10,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
435
Previous 435
-0.0%
Holding current value
$10,300
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$70 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$68.7 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$57.5 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.9 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39.8 Million0.03% of portfolio